Variant report

Variant	rs188240946
Chromosome Location	chr14:103839565-103839566
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr14:103819429..103822833-chr14:103836340..103840943,4	MCF-7	breast:
2	chr14:103811082..103813632-chr14:103837787..103840211,3	K562	blood:
3	chr14:103799041..103818802-chr14:103836567..103862153,82	K562	blood:
4	chr14:103838998..103840691-chr14:103845368..103847242,2	MCF-7	breast:
5	chr14:103839137..103840802-chr14:103851117..103853493,2	MCF-7	breast:
6	chr14:103836563..103839985-chr14:103850679..103852849,4	MCF-7	breast:
7	chr14:103800331..103802463-chr14:103838938..103841320,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000272533	Chromatin interaction
ENSG00000075413	Chromatin interaction
ENSG00000100664	Chromatin interaction

Extended variants
information (count: 7 )
Associated
traits (count: 0)

Variant overlapped rSNPs/rCNVs (count:7 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1042714	chr14:103085298-103860730	Enhancers Flanking Active TSS Strong transcription ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3' Active TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	114 gene(s)	inside rSNPs	diseases
2	nsv1049747	chr14:103126148-103955984	Weak transcription Enhancers Bivalent/Poised TSS Genic enhancers Flanking Active TSS Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	113 gene(s)	inside rSNPs	diseases
3	nsv534254	chr14:103470073-104023906	Bivalent Enhancer Enhancers Active TSS Weak transcription Flanking Active TSS Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	125 gene(s)	inside rSNPs	diseases
4	nsv9168	chr14:103531729-103913306	Enhancers Weak transcription Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Active TSS Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	92 gene(s)	inside rSNPs	diseases
5	esv3332028	chr14:103581471-104328811	Weak transcription Active TSS Enhancers Strong transcription Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	162 gene(s)	inside rSNPs	diseases
6	nsv542200	chr14:103838939-103868007	Enhancers Flanking Active TSS Active TSS Weak transcription Genic enhancers Bivalent/Poised TSS Transcr. at gene 5' and 3' ZNF genes & repeats Strong transcription Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	15 gene(s)	inside rSNPs	diseases
7	nsv983859	chr14:103839500-103844345	Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription Bivalent/Poised TSS	TF binding region Chromatin interactive region	4 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:40 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr14:103837600-103839600	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr14:103837600-103839800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
3	chr14:103837600-103839800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
4	chr14:103837600-103840000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
5	chr14:103838200-103840000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr14:103838200-103840000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr14:103838400-103839600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
8	chr14:103838400-103839600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
9	chr14:103838400-103839600	Enhancers	Esophagus	oesophagus
10	chr14:103838400-103839600	Enhancers	Spleen	Spleen
11	chr14:103838400-103839600	Enhancers	HMEC	breast
12	chr14:103838400-103839600	Enhancers	NHDF-Ad	bronchial
13	chr14:103838400-103839600	Enhancers	NHLF	lung
14	chr14:103838400-103839800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
15	chr14:103838400-103839800	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr14:103838400-103839800	Enhancers	NHEK	skin
17	chr14:103838600-103839600	Enhancers	HUVEC	blood vessel
18	chr14:103838600-103839600	Enhancers	Monocytes-CD14+_RO01746	blood
19	chr14:103838600-103839800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
20	chr14:103838600-103839800	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
21	chr14:103838800-103839600	Enhancers	ES-I3 Cell Line	embryonic stem cell
22	chr14:103838800-103839600	Enhancers	ES-WA7 Cell Line	embryonic stem cell
23	chr14:103838800-103839600	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr14:103838800-103839600	Enhancers	HUES48 Cell Line	embryonic stem cell
25	chr14:103838800-103839600	Enhancers	iPS-15b Cell Line	embryonic stem cell
26	chr14:103838800-103839600	Flanking Active TSS	NH-A	brain
27	chr14:103838800-103839800	Enhancers	K562	blood
28	chr14:103838800-103840000	Enhancers	Fetal Adrenal Gland	Adrenal Gland
29	chr14:103839000-103839600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr14:103839000-103839600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
31	chr14:103839000-103839600	Enhancers	H9 Cell Line	embryonic stem cell
32	chr14:103839000-103839600	Enhancers	Hela-S3	cervix
33	chr14:103839200-103839600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
34	chr14:103839200-103839600	Enhancers	HSMM	muscle
35	chr14:103839200-103839600	Flanking Active TSS	Osteobl	bone
36	chr14:103839200-103850800	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
37	chr14:103839400-103839600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
38	chr14:103839400-103839600	Enhancers	A549	lung
39	chr14:103839400-103839600	Bivalent Enhancer	HepG2	liver
40	chr14:103839400-103840400	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links